Waddell & Reed Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,010,599
Closed -$8.03M 474
2019
Q2
$8.03M Sell
1,010,599
-892,046
-47% -$10.6M 0.02% 420
2019
Q1
$23.9M Sell
1,902,645
-697,397
-27% -$11M 0.06% 321
2018
Q4
$51.9M Buy
2,600,042
+896,745
+53% +$20.7M 0.15% 188
2018
Q3
$48.4M Buy
1,703,297
+530,123
+45% +$12.6M 0.11% 224
2018
Q2
$24.7M Buy
1,173,174
+7,687
+0.7% +$145K 0.06% 306
2018
Q1
$16.6M Sell
1,165,487
-7,900
-0.7% -$113K 0.04% 352
2017
Q4
$14.4M Sell
1,173,387
-745,800
-39% -$10.5M 0.03% 377
2017
Q3
$34.2M Buy
1,919,187
+837,000
+77% +$17.2M 0.08% 277
2017
Q2
$27.4M Buy
1,082,187
+148,900
+16% +$3.58M 0.06% 315
2017
Q1
$20.8M Buy
933,287
+686,200
+278% +$13.2M 0.04% 345
2016
Q4
$3.66M Sell
247,087
-178,900
-42% -$3.52M 0.01% 515
2016
Q3
$10.5M Buy
425,987
+253,000
+146% +$5.91M 0.02% 408
2016
Q2
$3.32M Hold
172,987
0.01% 530
2016
Q1
$1.83M Buy
172,987
+42,300
+32% +$437K ﹤0.01% 577
2015
Q4
$1.58M Sell
130,687
-12,613
-9% -$186K ﹤0.01% 604
2015
Q3
$2.29M Buy
+143,300
New +$2.8M ﹤0.01% 561

Other funds holding EVH

Waddell & Reed Financial's EVH Position: Q3 2019 in Review

Waddell & Reed Financial sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 1,010,599 shares — an estimated $8.03M sold.

Waddell & Reed Financial first reported a position in EVH in Q3 2015 and held it in 16 quarters. The position peaked at $51.9M in Q4 2018. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.

  • Waddell & Reed Financial reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 1,010,599 Evolent Health shares in Q3 2019, an estimated $8.03M.
  • Waddell & Reed Financial first reported a position in Evolent Health in Q3 2015 and held it in 16 quarters.
  • Waddell & Reed Financial's Evolent Health position peaked at $51.9M in Q4 2018.
  • 174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.

Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.